SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-032082
Filing Date
2023-02-10
Accepted
2023-02-10 13:00:54
Documents
2
Group Members
GILBERT H. KLIMAN (A MANAGING DIRECTOR OF INTERWEST MANAGEMENT PARTNERS X, LLC)INTERWEST MANAGEMENT PARTNERS X, LLC (THE GENERAL PARTNER OF INTERWEST PARTNERS X, LP)KEVAL DESAI (A VENTURE MEMBER OF INTERWEST MANAGEMENT PARTNERS X, LLC)KHALED A. NASR (A VE

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d396468dsc13ga.htm SC 13G/A 100650
2 EX-99.A d396468dex99a.htm EX-99.A 4988
  Complete submission text file 0001193125-23-032082.txt   107496
Mailing Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022
Business Address C/O INTERWEST PARTNERS 467 FIRST STREET SUITE 201 LOS ALTOS CA 94022 650-854-8585
INTERWEST PARTNERS X LP (Filed by) CIK: 0001443898 (see all company filings)

IRS No.: 263131621 | State of Incorp.: CA
Type: SC 13G/A

Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 23610050
SIC: 2834 Pharmaceutical Preparations